TABLE 3.
Factor | Overall cohort | Matched cohort | ||||
---|---|---|---|---|---|---|
HR | 95% CI | p value | HR | 95% CI | p value | |
Stomach cancer | 0.89 | (0.87–0.92) | <0.0001 | 0.88 | (0.86–0.91) | <0.0001 |
Breast cancer | 0.94 | (0.88–1.00) | 0.0416 | 0.96 | (0.89–1.02) | 0.2062 |
Colorectal cancer | 0.91 | (0.88–0.93) | <0.0001 | 0.90 | (0.87–0.93) | <0.0001 |
Lung cancer | 0.87 | (0.85–0.88) | <0.0001 | 0.87 | (0.86–0.89) | <0.0001 |
Liver cancer | 0.91 | (0.89–0.94) | <0.0001 | 0.91 | (0.89–0.94) | <0.0001 |
Prostate cancer | 0.87 | (0.82–0.93) | <0.0001 | 0.89 | (0.83–0.94) | 0.0002 |
We adjusted age, gender, anti‐cancer drug use, and stage of cancer.
Abbreviations: CI, Confidence interval; HR, hazard ratios.